avian
influenza
ai
devast
poultri
diseas
seriou
econom
consequ
commerci
poultri
industri
ai
also
signific
public
health
concern
recent
highli
pathogen
avian
influenza
outbreak
caus
also
human
death
asia
europ
north
africa
accord
world
health
organ
updat
sinc
confirm
case
human
infect
report
die
due
diseas
complic
howev
avian
influenza
virus
includ
lowpathogen
avian
influenza
lpai
also
risk
public
health
instanc
lpai
subtyp
infect
chicken
mild
asymptomat
easili
overlook
howev
share
similar
receptor
bind
epitop
human
influenza
virus
infect
human
risk
lpai
subtyp
becom
highpathogen
avian
influenza
hpai
virus
chicken
due
constant
viru
shed
transmiss
new
bird
within
flock
neighbor
flock
vaccin
effect
way
prevent
viral
diseas
poultri
howev
routin
vaccin
ai
wide
practic
throughout
world
mainli
surveil
reason
desir
routin
vaccin
constant
reformul
ai
vaccin
requir
accord
circul
field
viru
cumbersom
case
immedi
outbreak
current
vaccin
ai
virus
reduc
mortal
clinic
sign
shed
transmiss
viru
poultri
capabl
prevent
infect
viru
replic
design
univers
influenza
vaccin
major
focu
research
influenza
vaccinolog
field
extern
domain
matrix
protein
one
main
interest
gener
univers
ai
vaccin
encod
separ
open
read
frame
segment
influenza
viru
genom
locat
viral
envelop
project
surfac
viru
tetram
compos
amino
acid
form
domain
extern
domain
transmembran
domain
intern
domain
extern
domain
recogn
host
immun
system
initi
vaccin
ferret
whole
mor
recombin
vaccinia
viru
show
evid
protect
howev
later
vaccin
construct
use
plasmid
recombin
salmonella
express
induc
signific
protect
term
reduct
viru
growth
mortal
mice
chicken
respect
multipl
antigen
peptid
construct
contain
induc
strong
antibodi
titer
serum
mice
result
signific
protect
influenza
viru
challeng
liang
et
al
show
import
cell
nasal
resist
protect
viru
assum
memori
th
cell
also
may
import
role
protect
viru
nose
trachea
mice
de
filett
et
al
use
hepat
b
viru
core
particl
hbc
carrier
fuse
conserv
region
human
influenza
viru
either
cterminu
hbc
insert
immunedomin
loop
hbc
immun
mice
vaccin
protect
lethal
challeng
antigen
epitop
pathogen
peptid
capabl
induc
immun
respons
howev
small
size
limit
immunogen
therefor
usual
larger
carrier
protein
bovin
serum
albumin
bsa
keyhol
limpet
hemocyanin
klh
viruslik
particl
vlp
requir
optim
immunogen
structur
organ
epitop
carrier
critic
induc
stronger
immun
respons
deni
et
al
demonstr
monomer
form
peptid
immunogen
huleatt
et
al
tri
solv
problem
ad
copi
peptid
platform
use
peptid
nanoparticl
platform
display
peptid
host
immun
system
nanoparticl
repres
novel
type
repetit
antigen
display
system
allow
present
peptid
high
densiti
either
monomer
tetramer
form
idea
first
present
raman
et
al
monomer
peptid
compos
two
coil
coil
connect
short
linker
region
associ
coil
coil
induc
selfassembl
monom
spheric
nanoparticl
either
icosahedr
octahedr
symmetri
figur
accord
comput
model
potenti
nanoparticl
serv
platform
vaccin
appar
oppos
live
attenu
vaccin
risk
infect
within
vaccin
popul
furthermor
eas
speed
protein
express
purif
selfassembl
nanoparticl
reduc
cost
time
largescal
product
concept
success
use
design
malaria
sar
vaccin
prototyp
present
biophys
character
nanoparticl
immunolog
profil
use
chicken
test
anim
result
suggest
selfassembl
polypeptid
nanoparticl
show
promis
potenti
vaccin
ai
dna
code
nanoparticl
construct
prepar
use
standard
molecular
biolog
procedur
shortli
plasmid
contain
peptid
monom
tabl
construct
clone
complementari
oligonucleotid
cccgggggggcagcggcagcctgctgaccgaagtg
gaaaccccgacccgcaacggctgggaataatgaattc
encod
avian
epitop
flank
residu
arggsgslltevetptrngw
e
xmaiecori
restrict
site
basic
sapn
express
construct
yield
gener
first
clone
tetramer
oligomer
domain
tetrabrachion
bamhibsshii
restrict
site
ppept
figur
clone
complementari
oligonucleotid
atgcatccctggttccgcgtggaagcctgctgaccg
aagtggaaaccccgacccgcaacggctgggaatgca
aatgcagcgatagcagcggatcc
code
slightli
longer
avian
sequenc
haslltevetptrngweckcsdssg
includ
flank
residu
ntermin
nsiibamhi
restrict
site
construct
made
replac
nanoparticl
fragment
sequenc
plasmid
transform
escherichia
coli
cell
grown
luria
broth
ampicillin
express
induc
isopropyl
four
hour
induct
cell
remov
harvest
centrifug
min
cell
pellet
store
pellet
thaw
ice
suspend
lysi
buffer
consist
urea
mm
mm
tri
ph
mm
imidazol
mm
phosphin
tcep
cell
lyse
sonic
lysat
clear
centrifug
min
clear
lysat
incub
ninta
agaros
bead
qiagen
valencia
ca
usa
least
hour
column
wash
lysi
buffer
buffer
contain
urea
mm
mm
tri
ph
mm
imidazol
mm
tcep
protein
elut
ph
gradient
urea
mm
mm
citrat
mm
imidazol
mm
tcep
subsequ
wash
done
ph
follow
ph
gradient
gradient
lysi
buffer
increas
imidazol
strength
use
elut
protein
puriti
assess
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
shown
figur
protein
solut
filter
polyvinyliden
fluorid
membran
filter
millipor
billerica
usa
nanoparticl
selfassembl
perform
dialysi
buffer
contain
urea
mm
tri
ph
mm
nacl
glycerol
protein
concentr
mgml
follow
dialysi
buffer
contain
decreas
concentr
urea
two
chang
buffer
without
urea
follow
selfassembl
nanoparticl
solut
filter
filter
dynam
light
scatter
experi
carri
zetas
nano
instrument
malvern
worcestershir
uk
nm
hene
laser
measur
carri
buffer
contain
mm
tri
ph
mm
nacl
glycerol
sampl
neg
stain
uranyl
acet
spi
suppli
westchest
pa
usa
observ
fei
tecnai
stem
acceler
voltag
kv
fei
hillsboro
oregon
peptid
concentr
construct
mgml
sampl
dialyz
mm
sodium
phosphat
ph
mm
nacl
glycerol
concentr
dilut
peptid
concentr
mgml
mgml
circular
dichroism
measur
perform
room
temperatur
use
appli
photophys
surrey
uk
pi
star
spectropolarimet
take
measur
nm
influenza
viru
use
direct
challeng
ai
studi
low
pathogen
influenza
low
pathogen
use
hyperimmun
serum
product
provid
charl
river
avian
vaccin
servic
storr
ct
virus
grown
titer
embryon
specif
pathogenfre
spf
chicken
egg
previous
describ
spf
line
white
leghorn
chicken
egg
obtain
cornel
univers
ithaca
ny
egg
hatch
univers
connecticut
poultri
farm
hatch
chicken
move
offic
anim
research
servic
oar
facil
week
brooder
free
access
water
standard
starter
diet
chicken
divid
group
bled
baselin
serolog
transfer
isol
equip
higheffici
particul
air
hepa
filter
provid
commerci
diet
water
ad
libitum
previous
describ
plaqu
reduct
assay
modifi
use
evalu
viru
neutral
activ
collect
sera
vaccin
briefli
serum
sampl
treatment
group
pool
equal
volum
dilut
pool
serum
lpai
subtyp
mix
incub
min
commerci
avail
antibodi
prosciinc
poway
ca
use
dilut
control
antibodi
activ
chicken
embryo
kidney
cell
cekc
monolay
plate
wash
twice
prewarm
pb
mixtur
ad
cekc
monolay
plate
incub
min
inoculum
remov
wash
prewarm
pb
overlaid
agar
univers
connecticut
cell
cultur
facil
minimum
essenti
medium
eagl
mem
h
plate
check
plaqu
format
evalu
fix
methanol
stain
crystal
violet
plaqu
count
epitop
includ
nanoparticl
platform
epitop
link
use
coat
elisa
plate
briefli
individu
well
flatbottom
immulon
plate
nuncthermo
fisher
scientif
rochest
ny
coat
tetramer
nanoparticl
interest
antigen
adhes
allow
proceed
overnight
plate
rins
tween
phosphatebuff
salin
pb
pbstween
thermofish
block
bsa
pb
solut
plate
incub
h
overnight
preliminari
studi
show
differ
result
incub
plate
rins
time
pbstween
incub
h
room
temperatur
previous
collect
sera
briefli
serial
dilut
serum
sampl
prepar
pb
solut
contain
bsa
hyperimmun
serum
previous
infect
bird
lpai
subtyp
commerci
antibodi
use
posit
control
sera
healthi
unvaccin
bird
use
neg
control
appropri
wash
peroxidaseconjug
goat
antichicken
igi
sigma
aldrich
prepar
dilut
pb
ad
well
plate
incub
addit
hour
room
temperatur
subsequ
rins
plate
develop
use
tetramethylbenzidin
tmb
peroxidas
substrat
thermo
fisher
scientif
inc
rockford
il
follow
room
temperatur
incub
period
min
absorb
read
spectramax
micropl
reader
molecular
devic
sunnyval
ca
nm
order
gener
standard
curv
realtim
pcr
transcrib
standard
rna
vitro
use
ribomax
express
largescal
rna
product
system
promega
madison
wi
briefli
rna
extract
done
use
trizol
reagent
invitrogen
carlsbad
ca
accord
manufactur
code
region
gene
lpai
subtyp
amplifi
use
previous
describ
univers
primer
rtpcr
perform
use
qiagen
onestep
rtpcr
kit
qiagen
valencia
ca
accord
standard
manufactur
protocol
pcr
product
visual
electrophoresi
ethidiumbromidestain
mm
trisacet
ph
mm
edta
agaros
gel
uv
light
amplifi
fragment
excis
gel
cdna
recov
agaros
gel
use
qiaquick
gel
extract
kit
qiagen
valencia
ca
accord
manufactur
protocol
purifi
dna
product
ligat
pcr
vector
invitrogen
carlsland
ca
accord
manufactur
protocol
gener
plasmid
confirm
pcr
posit
plasmid
sequenc
dna
biotechnolog
facil
univers
connecticut
six
microgram
plasmid
dna
linear
use
unit
restrict
enzym
bam
hi
h
linear
dna
use
templat
vitro
transcript
reaction
ribomax
express
largescal
rna
product
system
promega
madison
wi
accord
manufactur
recommend
vitro
transcript
reaction
h
possibl
remain
plasmid
dna
digest
dnase
purifi
rna
quantifi
spectrophotomet
nanodrop
thermo
fisher
scientif
wilmington
de
copi
number
purifi
rna
determin
use
previous
describ
method
use
gener
real
time
standard
curv
studi
realtim
rtpcr
perform
use
previous
publish
primer
aga
tga
gtc
ttc
taa
ccg
agg
tcg
tgc
aaa
aac
atc
ttc
aag
tct
ctg
quantif
viral
load
rna
extract
done
swab
sampl
follow
pcr
duplic
triplic
use
rna
per
pcr
reaction
briefli
power
sybr
green
rnatoct
kit
appli
biosystem
foster
citi
ca
use
reaction
mixtur
pcr
run
standard
design
plate
viral
load
calcul
use
fluoresc
data
acquir
end
anneal
step
amount
unknown
sampl
extrapol
base
standard
curv
report
viral
copi
number
prior
vaccin
challeng
studi
pilot
studi
perform
evalu
pathogen
viru
determin
peak
viru
shed
measur
viral
copi
number
tracheal
cloacal
sampl
chicken
variou
time
point
postinfect
subtyp
lowpathogen
avian
influenza
viru
lpai
briefli
thirti
spf
chicken
divid
group
ten
bled
baselin
serolog
transfer
isol
equip
hepa
filter
week
age
chicken
inocul
intranas
intraocularli
ml
dilut
allanto
fluid
depend
treatment
group
chicken
lowdos
challeng
group
receiv
ml
dilut
allanto
fluid
contain
wherea
highdos
challeng
group
receiv
ml
allanto
fluid
contain
third
group
chicken
remain
separ
isol
neg
control
tracheal
cloacal
swab
collect
day
postinfect
use
bd
univers
viral
transport
uvt
kit
becton
dickinson
nj
univers
viral
transport
polyest
swab
becton
dickinson
nj
upon
determin
peak
viru
shed
appropri
infecti
dose
pilot
studi
vaccin
challeng
trial
initi
briefli
spf
chicken
divid
six
group
seven
receiv
first
inocul
week
age
follow
two
booster
two
week
apart
week
week
hatch
describ
tabl
preced
inject
nanoparticl
concentr
use
amicon
centrifug
filter
unit
kda
mwco
millipor
billerica
concentr
determin
absorb
nm
nanoparticl
qualiti
assur
dl
nanoparticl
vaccin
construct
emulsifi
either
freund
complet
adjuv
prime
freund
incomplet
adjuv
booster
inject
pector
muscl
chicken
two
week
second
booster
bird
except
neg
control
group
challeng
lpai
subtyp
briefli
bird
receiv
ml
allanto
fluid
contain
lpai
subtyp
divid
among
eye
nasal
caviti
oropharynx
temporarili
block
fresh
air
deliveri
isol
fresh
air
resum
min
follow
challeng
last
bird
isol
although
clinic
sign
associ
lpai
virus
rare
observ
possibl
clinic
symptom
daili
presenc
symptom
sever
record
tracheal
cloacal
swab
taken
bird
day
challeng
place
ml
uvt
tube
becton
dickinson
nj
blood
sampl
bird
collect
booster
well
two
week
second
booster
prior
challeng
blood
sampl
collect
separ
blood
tube
serum
separ
place
tube
h
room
temperatur
overnight
follow
min
centrifug
rpm
collect
serum
sampl
store
analysi
obviou
model
selfassembl
protein
particl
viral
capsid
capsid
spheric
virus
often
icosahedr
symmetri
due
need
build
larg
encapsul
structur
mani
copi
capsid
protein
icosahedron
effici
way
accomplish
util
pentamer
trimer
coil
coil
built
selfassembl
nanoparticl
use
threefold
fivefold
symmetri
icosahedron
pentamer
coiledcoil
motif
monom
taken
cartilag
oligomer
matrix
protein
comp
trimer
de
novo
design
coil
coil
selfassembl
occur
coiledcoil
domain
differ
monom
associ
form
icosahedr
nanoparticl
figur
nanoparticl
sort
architectur
use
vaccin
platform
extend
end
monom
epitop
sequenc
speci
nanoparticl
follow
plan
tabl
result
repetit
display
monomer
form
surfac
nanoparticl
peptid
icosahedr
nanoparticl
lack
ctermin
five
residu
avoid
problem
disulfid
crosslink
presum
requir
nativ
tetramer
conform
proper
format
although
simplest
icosahedr
particl
icosahedr
symmetri
made
polypeptid
chain
may
also
possibl
particl
possess
higher
triangul
number
result
particl
even
greater
molecular
mass
hand
nativ
conform
tetram
henc
elicit
conform
specif
antibodi
antigen
display
vaccin
particl
ideal
tetramer
mind
design
peptid
tabl
instead
pentamer
coil
coil
polypeptid
use
tetramer
coiledcoil
motif
protein
tetrabrachion
selfassembl
use
peptid
would
result
nanoparticl
threefold
fourfold
symmetri
axe
octahedr
symmetri
oppos
larger
icosahedr
octahedr
particl
would
polypeptid
chain
addit
epitop
constrain
nativ
tetramer
conform
fulllength
contain
two
cystein
residu
format
disulfid
bridg
cystein
adjac
chain
oxid
condit
thought
stabil
tetramer
conform
speed
eas
protein
express
purif
well
selfassembl
process
contribut
overal
viabil
technolog
vaccin
platform
facilit
purif
includ
polyhistidin
tag
ntermin
end
peptid
enabl
detect
antibodi
tetramer
peptid
design
tabl
link
coil
coil
whose
oligomer
state
determin
ident
amino
acid
residu
key
posit
coil
coil
case
tetramer
version
use
affix
tetramer
protein
constrain
tetramer
conform
effect
similar
experienc
end
tetramer
coil
coil
tetrabrachion
nanoparticl
howev
coil
coil
sequenc
differ
guarante
antibodi
bound
specif
tetramer
version
coil
coil
part
nanoparticl
dynam
light
scatter
reveal
form
particl
whose
hydrodynam
diamet
distribut
peak
nm
distribut
peak
nm
figur
also
noteworthi
size
distribut
peak
broader
suggest
former
higher
degre
polydispers
result
confirm
transmiss
electron
microscopi
figur
see
nanoparticl
form
diamet
compar
measur
dynam
light
scatter
seen
micrograph
neither
form
nanoparticl
perfectli
spheric
morpholog
may
way
explain
polydispers
observ
dynam
light
scatter
doubl
minima
found
circular
dichroism
confirm
alpha
helic
structur
nanoparticl
figur
appear
exhibit
behavior
much
less
may
partli
due
larger
epitop
sequenc
peptid
compar
use
plaqu
reduct
assay
perform
use
pool
serum
chicken
inocul
show
signific
p
differ
compar
control
nonvaccin
chicken
serum
commerci
antibodi
immun
respons
monitor
determin
titer
igi
three
differ
time
point
week
inocul
chicken
inocul
develop
high
level
antibodi
inject
construct
anamnest
respons
clearli
seen
plate
coat
nanoparticl
tetramer
respect
tabl
figur
investig
antibodi
level
specif
antibodi
measur
use
plate
coat
tetramer
peptid
evalu
specif
antibodi
tetramer
rather
whole
particl
result
studi
indic
chicken
second
booster
antibodi
level
level
previou
result
mice
backbon
differ
malaria
epitop
shown
dose
level
also
higher
shown
requir
mice
could
lower
haplotypespecif
immunogen
particl
chicken
rout
administr
mice
intraperiton
intranas
bodi
weight
mice
compar
chicken
differ
immun
system
repertoir
mammalian
avian
speci
futur
studi
chang
administr
rout
anoth
approach
reduc
dose
vaccin
construct
also
coat
plate
inactiv
purifi
viru
observ
seroconvers
chicken
challeng
viru
week
last
boost
result
indic
whole
viru
respons
higher
expect
hyperimmun
serum
figur
howev
elisa
respons
chicken
vaccin
whole
viru
react
similarli
coat
plate
figur
b
protect
efficaci
antibodi
respons
induc
differ
construct
assess
evalu
viral
shed
post
challeng
determin
peak
shed
viral
copi
number
measur
tracheal
cloacal
sampl
chicken
infect
lpai
viru
briefli
pilot
studi
chicken
infect
viru
use
real
time
rtpcr
tracheal
cloacal
viru
shed
evalu
day
postinfect
found
good
indic
viru
shed
first
signific
p
rise
tracheal
cloacal
viru
shed
observ
day
postinfect
magnifi
peak
tracheal
shed
day
postinfect
take
account
result
vaccin
challeng
trial
individu
tracheal
cloacal
swab
collect
day
challeng
better
determin
protect
result
realtim
rtpcr
test
cloacal
tracheal
swab
sampl
taken
day
vaccin
challeng
studi
shown
figur
determin
viral
load
tracheal
cloacal
swab
sampl
day
follow
challeng
lpai
subtyp
reduct
cloacal
oropharyng
shed
vaccin
bird
signific
chicken
vaccin
freund
adjuv
viru
shed
evalu
day
day
challeng
swab
test
viru
load
figur
seen
viru
shed
reduct
start
day
post
infect
signific
decreas
day
post
infect
current
avail
vaccin
induc
antibodi
specif
field
strain
close
relat
avian
influenza
strain
vaccin
kill
viru
vaccin
induc
shortliv
immun
lack
broad
crossreact
humor
immun
respons
recent
gener
univers
influenza
vaccin
use
conserv
peptid
region
among
sever
influenza
viru
strain
area
interest
human
influenza
vaccin
field
highli
conserv
region
among
influenza
virus
studi
possibl
univers
vaccin
candid
human
influenza
viru
infect
present
studi
protect
effici
two
differ
nanoparticl
construct
harbor
studi
possibl
vaccin
candid
lowpathogen
avian
influenza
infect
biophys
analysi
confirm
rel
regular
shape
size
degre
heterogen
though
molecular
weight
measur
still
remain
carri
high
resolut
structur
data
assum
nanoparticl
assembl
state
close
expect
icosahedr
octahedr
nanoparticl
respect
repetit
display
either
monomer
tetramer
form
specul
polyhistidin
tag
ntermin
end
monom
may
affect
selfassembl
process
final
nanoparticl
structur
immunogen
vaccin
attempt
produc
histag
free
version
nanoparticl
construct
either
reliabl
provid
pure
protein
never
adequ
selfassembl
similarli
attempt
includ
cell
epitop
increas
immun
respons
also
interf
nanoparticl
format
sinc
mani
variabl
affect
host
viru
shed
cours
diseas
prior
evalu
vaccin
construct
pathogen
challeng
lpai
subtyp
viru
evalu
biphas
viru
shed
observ
studi
lpai
subtyp
peak
tracheal
cloacal
shed
day
postinfect
vaccin
construct
provid
signific
viral
load
reduct
peak
viral
shed
immun
chicken
chicken
immun
harbor
tetramer
freund
adjuv
show
clear
reduct
cloacal
tracheal
excret
lpai
compar
challeng
control
group
result
immun
adjuv
without
adjuv
also
promis
improv
b
tcell
epitop
construct
desir
result
may
obtain
vaccin
design
repetit
bcell
epitop
display
consid
strategi
improv
humor
immun
respons
addit
repetit
antigen
display
nanoparticl
abl
present
nativ
tetramer
conform
correl
high
protect
antibodi
respons
specif
tetramer
elicit
support
assumpt
tetramer
present
result
studi
show
tetramer
stimul
specif
immun
respons
compar
monomer
present
induc
signific
protect
homolog
viru
challeng
fact
larg
portion
antibodi
respons
direct
carrier
epitop
figur
explain
fact
signific
portion
core
nanoparticl
also
expos
immun
system
compar
figur
henc
portion
also
induc
signific
immun
respons
studi
show
antibodi
neutral
antibodi
howev
capabl
bind
protein
abundantli
present
surfac
infect
cell
data
shown
describ
effici
delay
clearanc
viru
vaccin
chicken
base
previous
describ
nk
cell
involv
adcc
signific
improv
viru
clearanc
vaccin
chicken
tetramer
may
consid
new
vaccin
strategi
vaccin
chicken
kill
vaccin
nanoparticl
vaccin
order
provid
robust
protect
crossreact
immun
clearanc
case
emerg
new
strain
viru
howev
remain
risk
vaccin
may
caus
longterm
persist
hpai
poultri
flock
vaccin
could
prevent
viral
infect
rather
suppress
symptom
hpai
virusinfect
chicken
reduc
viru
shed
chicken
therebi
especi
case
hpai
infect
vaccin
may
make
infect
less
visibl
erad
viru
difficult
consequ
may
provid
good
opportun
hpai
viru
surviv
persist
poultri
flock
long
time
reason
plan
design
new
nanoparticl
construct
also
contain
fragment
hemagglutinin
addit
domain
immun
would
result
gener
neutral
hemagglutininspecif
antibodi
addit
diseas
modul
antibodi
studi
evalu
new
approach
immun
chicken
ai
use
nanoparticl
platform
carri
antigen
epitop
design
test
new
nanoparticl
vaccin
demonstr
effect
tool
stimul
immun
respons
b
tcell
epitop
therefor
applic
nanoparticl
platform
facilit
develop
new
gener
vaccin
harbor
conserv
epitop
avian
influenza
virus
would
render
ineffect
viral
mutat
antigen
shift
drift
nanotechnolog
describ
offer
opportun
rapidli
produc
new
vaccin
accord
emerg
new
strain
influenza
viru
without
go
timeconsum
step
product
current
use
manufactur
commerci
influenza
vaccin
futur
studi
chicken
lpai
infect
model
need
improv
evalu
clinic
sign
higher
viru
shed
may
help
better
evalu
viru
shed
specif
cloacal
viru
shed
also
vaccin
hpai
challeng
may
use
evalu
vaccin
effici
protect
highpathogen
ai
virus
